Advanced Medical Solutions Group PLC
LSE:AMS

Watchlist Manager
Advanced Medical Solutions Group PLC Logo
Advanced Medical Solutions Group PLC
LSE:AMS
Watchlist
Price: 192.6 GBX 0.21% Market Closed
Market Cap: 412.7m GBX
Have any thoughts about
Advanced Medical Solutions Group PLC?
Write Note
Section:
 

Relative Value

The Relative Value of one AMS stock under the Base Case scenario is 370.88 GBX. Compared to the current market price of 192.6 GBX, Advanced Medical Solutions Group PLC is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AMS Relative Value
Base Case
370.88 GBX
Undervaluation 48%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
82
vs Industry
32
Median 3Y
4.2
Median 5Y
5
Industry
2.3
Forward
2.3
More Details
37.7
P/E
P/E
Price to Earnings
37.7
vs History
22
vs Industry
17
Median 3Y
32.2
Median 5Y
33.8
Industry
23
Forward
17.4
More Details
27.7
P/OCF
P/OCF
Price to OCF
27.7
vs History
14
vs Industry
9
Median 3Y
24
Median 5Y
24
Industry
14.3
More Details
5
P/FCFE
P/FCFE
Price to FCFE
5
vs History
95
vs Industry
0
Median 3Y
31.8
Median 5Y
35.7
Industry
20
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
80
vs Industry
42
Median 3Y
2.2
Median 5Y
2.4
Industry
2.2
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
80
vs Industry
32
Median 3Y
3.7
Median 5Y
4.4
Industry
2.4
Forward
2
More Details
5.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.2
vs History
76
vs Industry
35
Median 3Y
6.4
Median 5Y
7.7
Industry
5
More Details
15.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
15.7
vs History
30
vs Industry
23
Median 3Y
15.7
Median 5Y
16.6
Industry
12.9
Forward
9.2
More Details
30
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
30
vs History
14
vs Industry
19
Median 3Y
21.9
Median 5Y
22.8
Industry
17.4
Forward
12.3
More Details
24.6
EV/OCF
EV/OCF
Enterprise Value to OCF
24.6
vs History
14
vs Industry
10
Median 3Y
20.7
Median 5Y
21.3
Industry
14
More Details
59.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
59.3
vs History
14
vs Industry
2
Median 3Y
47.1
Median 5Y
29.6
Industry
18.2
More Details
1.8
EV/IC
EV/IC
Enterprise Value to IC
1.8
vs History
80
vs Industry
36
Median 3Y
2.4
Median 5Y
2.7
Industry
1.9
More Details

Multiples Across Competitors

AMS Competitors Multiples
Advanced Medical Solutions Group PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Advanced Medical Solutions Group PLC
LSE:AMS
419.2m GBP 3.2 37.7 15.7 30
JP
Hoya Corp
TSE:7741
6.8T JPY 8.3 34.8 22.9 27.6
CH
Alcon AG
SIX:ALC
37.8B CHF 4.3 36 17.7 34.2
DK
Coloplast A/S
CSE:COLO B
175.9B DKK 6.5 34.8 22.4 26.4
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 37 18.7 22.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51.2B CNY 11.4 27.4 24 24
KR
HLB Inc
KOSDAQ:028300
10.1T KRW 194.8 -54.5 -83.8 -79.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.5B USD 4.4 15.3 10.5 11.9
CA
Bausch + Lomb Corp
NYSE:BLCO
6.2B USD 1.3 -16.9 16.5 55.2
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37 264.5 462
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.6 23.3 38.1

See Also

Summary
AMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMS stock valuation using valuation multiples.
Wall Street Estimates
AMS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.